Silence Therapeutics PLC (SLN) — Cash Flow Quality Index

Latest as of December 2024: -1.09x

Silence Therapeutics PLC (SLN) has a Cash Flow Quality Index of -1.09x as of December 2024. Operating cash flow of $-24.86 Million is below net income of $22.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Silence Therapeutics PLC operating cash flow efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.09x

Operating CF / Net Income

Operating Cash Flow

$-24.86 Million

USD

Net Income

$22.89 Million

USD

Data as of

Dec 2024

Most recent filing

Annual Cash Flow Quality Index for Silence Therapeutics PLC (None–None)

Year-by-year earnings quality comparison for Silence Therapeutics PLC. For live market cap and the full company financial profile, see how much is Silence Therapeutics PLC worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.